The FDA did not respond to a request for comment. U.S. Health Secretary Robert F. Kennedy Jr. has said that the agency's ...

Thoughts of suicide was confirmed as a side effect of finasteride (Propecia, Proscar), a 5-alpha reductase inhibitor approved ...

Only 13% of oncology trial press releases from major pharma companies include precise data — raising concerns about ...

Revisions to classification criteria ‘will ensure homogeneous trial populations’ with data-driven scoring, a standardized MRI ...

The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck & Co. Inc.’s (NYSE:MRK) Welireg (belzutifan) for ...

Anavex Life Sciences Corp (AVXL) showcases strong financial health and advances in Alzheimer's and schizophrenia treatments, ...

FDA grants Priority Review of application, with PDUFA target action date of September 12, 2025– –ORLADEYO would be the first ...

Enrollment and dosing underway in Phase 3 clinical trial (the“MIRACLE” trial) evaluating Annamycin (naxtarubicin) for the treatment of R/R AML </p ...

Operator: Ladies and gentlemen, thank you for standing by, and welcome. At this time all participants are in listen-only mode ...

Netherlands-based Azafaros, a clinical-stage company developing therapeutics for rare lysosomal storage disorders, has ...

MPox is endemic in DRC, and has continued to cause large numbers of cases in the WHO African Region. In April, 2025, the WHO has restated that MPox continues to be a Public Health Emergency of ...

Liver fibrosis is a gradually worsening condition marked by excessive collagen buildup resulting from ongoing liver damage. This abnormal wound-healing response distorts the liver's structure, ...